6037
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (603707)
Market Closed
12 Dec, 06:57
SSE SSE Primary ¥
9. 18
-0.09
-0.97%
¥
20.07B Market Cap
- P/E Ratio
0.4% Div Yield
12,902,971 Volume
- Eps
¥ 9.27
Previous Close Day Range
9.1 9.27
Year Range
9.1 14.86
Want to track 603707 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| 6037 603707 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. 28 Aug 2025 | | 0.13 | 0.13 |
| 6037 603707 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. 16 May 2025 | | - | - |
| 6037 603707 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. 17 May 2024 | | - | - |
| 6037 603707 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. 27 Oct 2023 | | - | - |
603707 Earnings Reports FAQ
What is the earnings per share (EPS) for 603707?
EPS data for 603707 is currently not available, as Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 603707 at this time, as Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
